Edition:
United States

IRIDEX Corp (IRIX.OQ)

IRIX.OQ on NASDAQ Stock Exchange Global Market

6.99USD
18 May 2018
Change (% chg)

$-0.02 (-0.29%)
Prev Close
$7.01
Open
$7.06
Day's High
$7.23
Day's Low
$6.93
Volume
3,121
Avg. Vol
5,287
52-wk High
$10.35
52-wk Low
$4.78

Chart for

About

IRIDEX Corporation is a provider of therapeutic based laser consoles, delivery devices and consumable instrumentation used to treat sight-threatening eye diseases in ophthalmology. The Company operates through ophthalmology segment. Its ophthalmology products consist of laser consoles, delivery devices and consumable instrumenta... (more)

Overall

Beta: 1.41
Market Cap(Mil.): $83.49
Shares Outstanding(Mil.): 11.63
Dividend: --
Yield (%): --

Financials

  IRIX.OQ Industry Sector
P/E (TTM): -- 34.72 32.53
EPS (TTM): -1.26 -- --
ROI: -42.82 8.07 12.63
ROE: -43.53 11.48 14.50

BRIEF-Iridex Corp Q1 Revenue $9.5 Million

* REITERATED ITS GUIDANCE FOR 2018 OF G6 PROBE SHIPMENTS OF 40,000 TO 45,000,

May 03 2018

BRIEF-Iridex Announces Availability Of G-Probe Illuminate Device In Europe

* IRIDEX CORP - AVAILABILITY OF G-PROBE ILLUMINATE DEVICE IN EUROPE Source text for Eikon: Further company coverage:

Mar 20 2018

BRIEF-Iridex Qtrly Loss Per Share $0.44

* IRIDEX ANNOUNCES 2017 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS

Mar 08 2018

BRIEF-Iridex Issues Voluntary Recall Of Trufocus Lio Premiere Laser Indirect Ophthalmoscope

* IRIDEX ISSUES VOLUNTARY RECALL OF TRUFOCUS LIO PREMIERE™ LASER INDIRECT OPHTHALMOSCOPE

Feb 23 2018

BRIEF-Blueline Capital Partners LP Reports 8.5 pct Passive Stake In Iridex Corp As Of Dec. 31, 2017

* BLUELINE CAPITAL PARTNERS LP REPORTS 8.5 PERCENT PASSIVE STAKE IN IRIDEX CORP AS OF DECEMBER 31, 2017 - SEC FILING‍​ Source text - (http://bit.ly/2F0uMll) Further company coverage:

Jan 22 2018

BRIEF-Iridex Corp ‍Filed Lawsuit Against Quantel Medical S.A

* IRIDEX CORP - ‍FILED LAWSUIT AGAINST QUANTEL MEDICAL S.A., QUANTEL USA, QUANTEL, S.A. IN U.S. DISTRICT COURT FOR NORTHERN DISTRICT OF CALIFORNIA​ Source text for Eikon: Further company coverage:

Jan 09 2018

Earnings vs. Estimates